NMR logo

Nomura Holdings (NMR) EBITDA

annual EBITDA:

$22.18B+$1.87B(+9.20%)
March 1, 2025

Summary

  • As of today (May 22, 2025), NMR annual EBITDA is $22.18 billion, with the most recent change of +$1.87 billion (+9.20%) on March 1, 2025.
  • During the last 3 years, NMR annual EBITDA has risen by +$17.58 billion (+382.24%).
  • NMR annual EBITDA is now at all-time high.

Performance

1-year change

+9.2%

3-year change

+382.24%

5-year change

+146.83%

15-year change

+180.84%

NMR EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

96.18%
NMR annual EBITDA is higher than 96.18% of companies in Financial Services sector

Range

All-time high

$22.18B
NMR annual EBITDA is currently at an all-time high

3-year low

$4.60B
NMR annual EBITDA is currently +382.24% above its 3-year low

Earnings dates

Last annual earnings report date

Mar 1, 2025
NMR previous annual earnings announcement was published on Mar 1, 2025

Next annual earnings report date

N/A
NMR next annual earnings announcement has not yet been scheduled

OtherNMRincome statement metrics

Annual revenue

$10.91B
NMR annual revenue is $10.91 billion

annual net income

$2.24B
NMR annual net profit is $2.24 billion

annual EBIT

$21.77B
NMR annual earnings before interest & taxes is $21.77 billion

Annual EPS

$0.73
NMR annual earnings per share is $0.73

quarterly EBITDA:

N/A
March 1, 2025

Summary

  • NMR quarterly EBITDA is not available.

Performance

3-month change

-

1-year change

-

3-year change

-

5-year change

-

NMR quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-time high

$5.63B
NMR quarterly EBITDA is currently at an all-time high

3-year low

$1.06B
NMR quarterly EBITDA is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 1, 2025
NMR previous earnings announcement was published on Mar 1, 2025

Next quarterly earnings report date

Jul 30, 2025
NMR next earnings announcement is scheduled for Jul 30, 2025

OtherNMRincome statement metrics

Quarterly revenue

$2.67B
NMR quarterly revenue is $2.67 billion

quarterly net income

$471.98M
NMR quarterly net profit is $471.98 million

quarterly EBIT

$4.75B
NMR quarterly earnings before interest & taxes is $4.75 billion

Quarterly EPS

$0.15
NMR quarterly earnings per share is $0.15

TTM EBITDA:

N/A
March 1, 2025

Summary

  • NMR TTM EBITDA is not available.

Performance

3-month change

-

1-year change

-

3-year change

-

5-year change

-

NMR TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-time high

$20.24B
NMR TTM EBITDA is currently at an all-time high

3-year low

$4.33B
NMR TTM EBITDA is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 1, 2025
NMR previous earnings announcement was published on Mar 1, 2025

Next quarterly earnings report date

Jul 30, 2025
NMR next earnings announcement is scheduled for Jul 30, 2025

OtherNMRincome statement metrics

TTM revenue

$11.25B
NMR TTM revenue is $11.25 billion

TTM net income

$2.24B
NMR TTM net profit is $2.24 billion

TTM EBIT

$21.78B
NMR TTM earnings before interest & taxes is $21.78 billion

TTM EPS

$0.73
NMR TTM earnings per share is $0.73

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

$22.18B
NMR annual EBITDA is $22.18 billion

annual net income

$2.24B
NMR annual net profit is $2.24 billion

annual interest expense

-
NMR annual interest expense value is unknown

annual income tax

$818.74M
NMR annual income tax is $818.74 million

annual D&A

$404.77M
NMR annual depreciation & amortization is $404.77 million

NMR EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9.2%--
3 y3 years+382.2%--
5 y5 years+146.8%--

NMR EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+382.2%
5 y5-yearat high+382.2%
alltimeall timeat high+725.4%

NMR EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
$22.18B(+9.2%)
-
-
Mar 2024
$20.31B(+101.3%)
$5.63B(+7.4%)
$20.24B(+10.7%)
Dec 2023
-
$5.24B(+5.7%)
$18.28B(+11.3%)
Sep 2023
-
$4.96B(+12.3%)
$16.43B(+22.9%)
Jun 2023
-
$4.41B(+20.2%)
$13.37B(+33.5%)
Mar 2023
$10.09B(+119.3%)
$3.67B(+8.4%)
$10.02B(+34.2%)
Dec 2022
-
$3.39B(+78.8%)
$7.47B(+38.9%)
Sep 2022
-
$1.89B(+78.2%)
$5.37B(+24.1%)
Jun 2022
-
$1.06B(-5.3%)
$4.33B(-5.7%)
Mar 2022
$4.60B(-4.4%)
$1.12B(-13.4%)
$4.59B(+75.8%)
Dec 2021
-
$1.30B(+52.2%)
$2.61B(-19.3%)
Sep 2021
-
$850.91M(-35.8%)
$3.24B(-14.7%)
Jun 2021
-
$1.33B(-254.3%)
$3.80B(-20.9%)
Mar 2021
$4.81B(-46.5%)
-$859.12M(-144.7%)
$4.80B(-29.4%)
Dec 2020
-
$1.92B(+36.3%)
$6.80B(-4.8%)
Sep 2020
-
$1.41B(-39.4%)
$7.15B(-19.3%)
Jun 2020
-
$2.33B(+104.1%)
$8.86B(-1.5%)
Mar 2020
$8.98B(+34.9%)
$1.14B(-49.7%)
$8.99B(-10.1%)
Dec 2019
-
$2.27B(-27.4%)
$10.00B(+12.0%)
Sep 2019
-
$3.12B(+26.9%)
$8.93B(+1.6%)
Jun 2019
-
$2.46B(+14.6%)
$8.79B(+9.3%)
Mar 2019
$6.66B(-15.6%)
$2.15B(+79.5%)
$8.05B(+4.4%)
Dec 2018
-
$1.20B(-59.9%)
$7.71B(-12.9%)
Sep 2018
-
$2.98B(+73.8%)
$8.85B(+13.8%)
Jun 2018
-
$1.72B(-5.1%)
$7.78B(-1.3%)
Mar 2018
$7.90B(+20.9%)
$1.81B(-22.7%)
$7.88B(+3.0%)
Dec 2017
-
$2.34B(+22.3%)
$7.66B(+9.0%)
Sep 2017
-
$1.91B(+5.2%)
$7.02B(+2.3%)
Jun 2017
-
$1.82B(+14.9%)
$6.86B(+5.1%)
Mar 2017
$6.53B(+37.0%)
$1.58B(-7.2%)
$6.53B(+14.3%)
Dec 2016
-
$1.71B(-2.7%)
$5.71B(+8.8%)
Sep 2016
-
$1.75B(+18.3%)
$5.25B(+16.8%)
Jun 2016
-
$1.48B(+93.7%)
$4.49B(-5.4%)
Mar 2016
$4.77B(-30.7%)
$765.80M(-38.4%)
$4.75B(-17.0%)
Dec 2015
-
$1.24B(+24.5%)
$5.72B(-10.0%)
Sep 2015
-
$998.41M(-42.5%)
$6.35B(-9.0%)
Jun 2015
-
$1.74B(+0.0%)
$6.97B(+2.2%)
Mar 2015
$6.88B(-3.8%)
$1.74B(-7.4%)
$6.83B(+1.2%)
Dec 2014
-
$1.88B(+15.4%)
$6.74B(+2.2%)
Sep 2014
-
$1.62B(+2.2%)
$6.60B(-0.6%)
Jun 2014
-
$1.59B(-3.9%)
$6.64B(-7.2%)
Mar 2014
$7.15B(-0.8%)
$1.65B(-4.5%)
$7.15B(-14.2%)
Dec 2013
-
$1.73B(+4.2%)
$8.33B(+5.7%)
Sep 2013
-
$1.66B(-21.0%)
$7.88B(+2.1%)
Jun 2013
-
$2.10B(-25.8%)
$7.72B(+9.9%)
Mar 2013
$7.21B
$2.83B(+120.7%)
$7.02B(+14.8%)
DateAnnualQuarterlyTTM
Dec 2012
-
$1.28B(-14.3%)
$6.12B(-7.4%)
Sep 2012
-
$1.50B(+6.4%)
$6.61B(+12.3%)
Jun 2012
-
$1.41B(-27.0%)
$5.89B(-7.0%)
Mar 2012
$6.35B(+29.1%)
$1.93B(+8.7%)
$6.33B(+8.2%)
Dec 2011
-
$1.78B(+129.5%)
$5.85B(+1.7%)
Sep 2011
-
$773.98M(-58.1%)
$5.75B(-3.9%)
Jun 2011
-
$1.85B(+27.7%)
$5.98B(+19.9%)
Mar 2011
$4.92B(+18.8%)
$1.45B(-13.8%)
$4.99B(+11.6%)
Dec 2010
-
$1.68B(+67.1%)
$4.47B(+19.7%)
Sep 2010
-
$1.01B(+17.3%)
$3.74B(-2.0%)
Jun 2010
-
$857.25M(-7.7%)
$3.81B(-7.6%)
Mar 2010
$4.14B(-216.8%)
$928.88M(-1.6%)
$4.12B(+181.6%)
Dec 2009
-
$944.40M(-12.6%)
$1.46B(-151.2%)
Sep 2009
-
$1.08B(-7.6%)
-$2.86B(-11.1%)
Jun 2009
-
$1.17B(-167.6%)
-$3.22B(-16.6%)
Mar 2009
-$3.55B(-150.2%)
-$1.73B(-48.8%)
-$3.86B(+28.0%)
Dec 2008
-
-$3.38B(-567.8%)
-$3.02B(-229.8%)
Sep 2008
-
$722.56M(+36.9%)
$2.32B(-32.1%)
Jun 2008
-
$527.94M(-159.5%)
$3.42B(-48.9%)
Mar 2008
$7.07B(-38.0%)
-$886.69M(-145.2%)
$6.71B(-37.6%)
Dec 2007
-
$1.96B(+7.5%)
$10.76B(-12.5%)
Sep 2007
-
$1.82B(-52.2%)
$12.29B(-6.0%)
Jun 2007
-
$3.81B(+20.6%)
$13.07B(+14.9%)
Mar 2007
$11.40B(+13.3%)
$3.16B(-9.5%)
$11.37B(+3.9%)
Dec 2006
-
$3.49B(+34.0%)
$10.95B(+2.3%)
Sep 2006
-
$2.61B(+23.3%)
$10.70B(+4.2%)
Jun 2006
-
$2.11B(-22.8%)
$10.27B(+5.3%)
Mar 2006
$10.06B(+89.4%)
$2.74B(-15.5%)
$9.76B(+20.1%)
Dec 2005
-
$3.24B(+48.8%)
$8.12B(+20.5%)
Sep 2005
-
$2.18B(+36.6%)
$6.74B(+20.3%)
Jun 2005
-
$1.60B(+44.7%)
$5.60B(+2.5%)
Mar 2005
$5.31B(-2.4%)
$1.10B(-40.7%)
$5.46B(-8.3%)
Dec 2004
-
$1.86B(+78.6%)
$5.95B(+14.7%)
Sep 2004
-
$1.04B(-28.5%)
$5.19B(-9.5%)
Jun 2004
-
$1.46B(-8.6%)
$5.74B(+2.0%)
Mar 2004
$5.44B(+87.6%)
$1.59B(+45.0%)
$5.62B(+26.1%)
Dec 2003
-
$1.10B(-30.8%)
$4.46B(+6.0%)
Sep 2003
-
$1.59B(+18.2%)
$4.21B(+21.3%)
Jun 2003
-
$1.34B(+211.2%)
$3.47B(+19.0%)
Mar 2003
$2.90B(-51.3%)
$431.44M(-49.0%)
$2.91B(+17.4%)
Dec 2002
-
$845.57M(-0.4%)
$2.48B(+51.6%)
Sep 2002
-
$849.35M(+7.7%)
$1.64B(+107.7%)
Jun 2002
-
$788.51M
$788.51M
Mar 2002
$5.96B(-13.1%)
-
-
Mar 2001
$6.86B(-13.4%)
-
-
Mar 2000
$7.92B
-
-

FAQ

  • What is Nomura Holdings annual EBITDA?
  • What is the all time high annual EBITDA for Nomura Holdings?
  • What is Nomura Holdings annual EBITDA year-on-year change?
  • What is the all time high quarterly EBITDA for Nomura Holdings?
  • What is the all time high TTM EBITDA for Nomura Holdings?

What is Nomura Holdings annual EBITDA?

The current annual EBITDA of NMR is $22.18B

What is the all time high annual EBITDA for Nomura Holdings?

Nomura Holdings all-time high annual EBITDA is $22.18B

What is Nomura Holdings annual EBITDA year-on-year change?

Over the past year, NMR annual EBITDA has changed by +$1.87B (+9.20%)

What is the all time high quarterly EBITDA for Nomura Holdings?

Nomura Holdings all-time high quarterly EBITDA is $5.63B

What is the all time high TTM EBITDA for Nomura Holdings?

Nomura Holdings all-time high TTM EBITDA is $20.24B
On this page